On this HIMSS TV episode, host Jessica Hagan talks with Naomi Fried. Naomi, founder and CEO of PharmStars, discusses the organizations 5th cohort entitled, "digital innovations in therapeutic delivery: supply chain to the patient interface" and the 11 startups graduated from the accelerator program.
On this HIMSS TV episode, host Jessica Hagan talks with Naomi Fried, Founder and CEO of PharmStars. Naomi shares information about PharmStars, the pharma-focused accelerator for digital health startups.
On this podcast, host Bozidar Jovicevic talks with Naomi Fried, Founder and CEO of PharmStars about bridging the “Pharma-Startup Gap.”
On this Shot of Digital Health Therapy podcast, hosts Jim Joyce and Eugene Borukhovich talk with Naomi Fried, Founder and CEO of PharmStars.
On this HIMSS TV episode, host Jessica Hagan talks with Naomi Fried, Founder and CEO of PharmStars. Naomi shares information about PharmStars, the pharma-focused accelerator for digital health startups and how it helps position startups to partner successfully with the pharmaceutical industry.
On this pharmaphorum podcast, host Jonah Comstock takes us to the PharmStars presentation in November 2022 at the Boston Seaport, with interviews conducted at the event. The topic: Innovations in Real-World Evidence.
In this episode of the Latest Dose, Naomi Fried, PhD, Founder & CEO of PharmStars and Steve Prewitt, SVP, Global Head of Digital Innovation at Sumitovant Biopharma, share the importance and significance of new entrants into the market.
A gap exists between pharma and digital health startup that prevents them from engaging in fruitful partnerships. What's going wrong?
To advance digital health, pharmaceutical companies and start-ups should partner. There are many benefits to both from working together.
Digital health is new and exciting, but also fraught with complexity. We need a framework to understand how to navigate our way through the world of Digital Healthcare.
What will 2020 and beyond bring for the digital health ecosystem?
Innovating in highly regulated industries can be challenging, but it is necessary. For innovation to flourish despite legal and regulatory obstacles, we must address innovation barriers head-on.
The ROI of digital health is more than just financial, it can take many other forms. Here are my top five.
2020 was not the year any of us expected, however in the world of digital health the growth of innovative solutions has been an unexpected silver lining.